Author:
Kisner D. L.,Catane R.,Muggia F. M.
Publisher
Springer Berlin Heidelberg
Reference15 articles.
1. Catane R, Ovejera AA, Houchens DP, Von Hoff DD, Davis HL Jr, Wolpert MK, Rozencweig M, Muggia FM (1978) Rationale for further clinical trials with 6-dia- zo-5-oxo-L-norleucine (DON) (abstr). Proc Am Assoc Cancer Res and Am Soc Clin Oncol 19:317
2. Cooney DA, Jayaram HN, Milman HA, Homan ER, Pittillo R, Geran RI, Ryan J, Rosenbluth RJ (1976) DON, CONV and DONV-III, pharmacologic and toxicologic studies. Biochem Pharmacol 25:1859–1870
3. Hill GJ, Larsen RR, Sas EM (1973) Cancer chemotherapy II. Results of 603 courses of therapy in 400 consecutive patients followed for 18-52 months. Oncology 27:137–152
4. Li MC (1961) Management of chariocarcinoma and related tumors of the uterus and testis. Med Clin North Am 45:661–676
5. Livingston RB, Vendetti JM, Cooney DA, Carter SK (1970) Glutamine antagonists in chemotherapy, vol 8. Academic, New York, pp 62–83
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献